Clinical Trials on Multiresistant Enterobacteriaceae in France

Total 37 results

Assistance Publique - Hôpitaux de Paris

Unknown

Existence in the Human Digestive Flora of Phages Able to Prevent the Acquisition of Multiresistant Enterobacteria (PHAGO-BMR)

Multiresistant Enterobacteriaceae

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Rectal Carriage of Carbapenemase Producing-Enterobacteriaceae on Admission to a French University Teaching Hospital (Prev-CPE)

Rectal Carriage of Carbapenemase Producing-Enterobacteriaceae

France
CHU de Reims

Completed

Qnr Genes in Enterobacteriaceae

Enterobacteriaceae Infection

France
Centre Hospitalier Universitaire de Besancon
University Hospital, Geneva; UMC Utrecht; University of Oxford; University Hospital... and other collaborators

Completed

Understanding and Modeling Reservoirs, Vehicles and Transmission of ESBL-producing Enterobacteriaceae in the Community and Long Term Care Facilities (MODERN)

Enterobacteriaceae Infections | Resistance Bacterial

France
University Hospital, Strasbourg, France

Recruiting

Carbapenem Antibiotic Therapy for VIM Carbapenemase-Producing Enterobacteriaceae Infections (CarbaVim)

Carbapenemase-Producing Enterobacteriaceae

France
University Hospital, Clermont-Ferrand
University Hospital, Estaing; Hopital Gabriel Montpied

Unknown

Assessment of the Prevalence of Extended-Spectrum Betalactamase Producing Enterobacteriaceae Among ICU Staff (REASSE)

Antibiotic Resistance | Extended-spectrum Betalactamase | Enterobacteriaceae | Escherichia Coli

France
Centre Hospitalier Universitaire, Amiens

Completed

Prevalence of Clinical Strains of Enterobacteria With Reduced Susceptibility to Carbapenems in the North-West Region of France (ERC)

Enterobacteriaceae

France
Nantes University Hospital

Completed

Prevalence of ESBL and CPE in French Nursing Homes (CARBEHPAD)

Enterobacteriaceae Infections

France
Centre Hospitalier Universitaire de Besancon

Unknown

Effect of Administration of 3rd Generation Cephalosporin on the Digestive Carrying of 3rd Generation Cephalosporin-resistant Enterobacteriaceae (CEF-IMPACT) (CEF-IMPACT)

Infectious Disease - Resistant Enterobacteriaceae (Diagnosis)

France
Groupe Hospitalier Paris Saint Joseph

Recruiting

Effect of Imipenem and Meropenem on the Digestive Microbiota and the Emergence and Carriage of Multidrug-resistant Bacteria (MERIMI)

Enterobacteriaceae Infections

France
Groupe Hospitalier Paris Saint Joseph
Hospital Avicenne

Completed

Impact of Beta-lactams on the Microbiota and Relative Fecal Abundance of Mulltidrug Resistant Bacteria

Enterobacterial Infection

France
CHU de Reims

Unknown

Prevalence of Enterobacteria With Decreased Susceptibility to Carbapenems in Eastern Inter- Region (CARBAFREST)

Infection With Beta-lactam Resistance in Enterobacteriaceae

France
Centre Hospitalier Universitaire de Besancon

Completed

Epidemiology of ST131 in Besançon University Hospital (coliST131)

Escherichia Coli Infections

France
Groupe Hospitalier Paris Saint Joseph

Active, not recruiting

Prognosis of Klebsiella ESBL Sepsis: Role of 2-HYDRoxy-myristate in Endotoxin Structure (PoKES2_HYDRES)

Klebsiella Infections

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Study of the Ecological and Evolutionary Dynamics of Escherichia Coli in the Digestive Commensal Flora (EVE)

Escherichia Coli; Infection, Intestinal

France
University Hospital, Bordeaux

Recruiting

Efficacy of Piperacillin-tazobactam as Empirical Antimicrobial Therapy for VAP Among ESBL-E Carriers. (PROBATAZO)

Enterobacteriaceae Infections

France
Centre Hospitalier Universitaire, Amiens

Completed

Nosocomial Outbreak of BHRe in an Intensive Care Unit During SARS-CoV-2 Pandemic (BHReICU)

Enterobacteriaceae Infections | Hospital-Acquired Infection

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Fecal Transplantation to Eradicate Colonizing Emergent Superbugs (FECES)

Enterobacteriaceae Infections | Fecal Microbiota Transplantation

France
GlaxoSmithKline

Completed

A Study to Evaluate Safety and Immunogenicity of 1 Booster Dose of 1790GAHB Vaccine in Healthy Adults Primed With 3 Doses of 1790GAHB Vaccine in Study H03_01TP Compared to 1 Vaccination of 1790GAHB in Either Subjects Who Received Placebo in the Same Study or naïve Subjects Not Part of H03_01TP Study

Dysentery, Bacillary

France
GSK Vaccines Institute For Global Health S.r.l.

Completed

A Phase 1, Dose Escalation Study, to Evaluate a New Shigella Sonnei Vaccine in Healthy Adults.

Shigellosis

France
Central Hospital, Nancy, France

Completed

Infections and Colonization With the Third Group of Enterobacteriaceae in the Intensive Care Unit (EB3REA)

Enterobacteriaceae Infections | Critically Ill | Antibiotic Resistant Infection

France
Centre Hospitalier Universitaire de Nice

Unknown

Role of the NLRP3 Inflammasome in Escherichia Coli and Staphylococcus Aureus Bacteria (NLRP3-Bact)

Staphylococcus Aureus | Escherichia Coli Infections

France
Central Hospital, Nancy, France

Terminated

Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia Coli (COLIFOX)

Urinary Tract Infections

France
University Hospital, Toulouse

Completed

Prospective Cohort Assessing the Role of the Genotoxin Colibactin From Escherichia Coli B2 in the Genesis of NASH (Coli-NASH)

Non-alcoholic Fatty Liver Disease

France
Institut Pasteur

Completed

Healthy Adult Volunteer Study for Two Doses of a Shigella Vaccine

Shigella Infection

France, United Kingdom
Assistance Publique - Hôpitaux de Paris

Completed

Prognostic Factors of Escherichia Coli Bloodstream Infections: Severity Score and Therapeutic Implications (SEPTICOLI)

Escherichia Coli Bloodstream Infection

France
MJM Bonten
Janssen Research & Development, LLC; Innovative Medicines Initiative

Completed

Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli (EXPECT-1) (EXPECT-1)

E.Coli Infections

United States, United Kingdom, Canada, France, Germany, Italy, Japan, Spain
Pherecydes Pharma

Unknown

Evaluation of Phage Therapy for the Treatment of Escherichia Coli and Pseudomonas Aeruginosa Wound Infections in Burned Patients (PHAGOBURN)

Wound Infection

Belgium, France, Switzerland
Assistance Publique - Hôpitaux de Paris

Terminated

Efficacy and Pharmacokinetic/Pharmacodynamic Parameters of Cefoxitin in Women With Acute Pyelonephritis Without Severity Symptoms Due to Extended-spectrum β-lactamase Producing Escherichia Coli (FOXICOLI)

Acute Pyelonephritis Without Severity Symptoms Due to ESBL-producing E.Coli

France
UMC Utrecht
Janssen Research & Development, LLC; Innovative Medicines Initiative

Completed

Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli-2 (EXPECT-2) (EXPECT-2)

E. Coli Infection

United States, Italy, United Kingdom, Canada, France, Germany, Japan, Spain
Enterome
Eurofins Optimed

Terminated

MOlecular BIomarkers and Adherent and Invasive Escherichia Coli (AIEC) Detection Study In Crohn's Disease Patients (MOBIDIC)

Crohn's Disease

United States, France, United Kingdom
Hospital Moinhos de Vento

Terminated

Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections (OPTIMISE)

Sepsis | Gram-Negative Bacterial Infections | Bacteremia | Severe Infection | Bloodstream Infection | Acinetobacter Infections | Pseudomonas Aeruginosa | Human | Carbapenem-Resistant Enterobacteriaceae Infection | Carbapenem Resistant Bacterial Infection

Brazil
University Hospital, Clermont-Ferrand

Completed

Psychological Evaluation According Colonic Colonization by Escherichia Coli of Patients After Colorectal Surgery (MicrobioPSY)

Colorectal Cancer

France
Janssen Research & Development, LLC

Active, not recruiting

A Study of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60 to 85 Years in Stable Health

Extraintestinal Pathogenic Escherichia Coli Prevention

United States, France, Belgium, Spain, Netherlands
University Hospital, Brest

Unknown

Intensive Care Unit Acquired Infections in Patients Colonized With Extended Spectrum Enterobacteriaceae (BMREA)

Bacteremia | Enterobacteriaceae Infections | Ventilator Associated Pneumonia | Abdominal Infection

France
University Hospital, Bordeaux

Completed

Outbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4 (SHU O104 CUB)

Escherichia Coli Infections | Hemolytic-uremic Syndrome

France
Janssen Research & Development, LLC

Recruiting

A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years

Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention

United States, United Kingdom, Korea, Republic of, Taiwan, Canada, Denmark, France, Thailand, New Zealand, Spain, China, Israel, Germany, Colombia, India, Netherlands, Australia, Japan, Sweden, Czechia, Italy

Clinical Trials on Multiresistant Enterobacteriaceae in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations